Inmagene

Public

San Diego, CaliforniaBiotechhttps://www.inmagenebio.com

Inmagene is now publicly traded

The data on this page reflects Inmagene's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jul 25, 2025

Est. Valuation at Exit

$347.22M

Total Funding Raised

$216M

Company Overview

Inmagene is a biotechnology company dedicated to developing innovative therapeutics for immunological and inflammatory diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

non-depleting anti-OX40 monoclonal antibodyimmunological and inflammatory disease therapeuticsatopic dermatitis biologicsIL-17A inhibitor for psoriatic arthritisextended half-life monoclonal antibodyalopecia areata therapeuticsnon-covalent reversible BTK inhibitoranti-IL-36R mAb for generalized pustular psoriasisclinical-stage immunology drug developmentbiotech drug in-licensing and co-developmentclinical-stage biotechnology company

Inmagene Comparables

Compare Inmagene with similar companies based on industry and business-model similarity.

Inmagene comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Elemental Biologics	48%

View all Comparables

Inmagene Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jul 25, 2025
Series C	Jun 1, 2021
Series B	Nov 9, 2020
Series A	Feb 1, 2020

View all Funding Rounds

Inmagene Investors

Notable investors and investment history

Inmagene investors
Investor	Rounds
HighLight Capital	Series C
SCVC	Series B
Omega Funds	Private Placement
Highlight Capital	Series C
Jiangsu Honghui Equity Investment Management	Series C
Triwise Capital	Series C
Blue Owl Capital	Private Placement

View all Investors

Inmagene Filings

Explore SEC and related filing metadata, where available.

Inmagene filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersSan Diego, California

Year Founded2019

Last FundingJul 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?